Massachusetts voters uphold recreational cannabis sales, as Idaho defeats an anti-legalization constitutional amendment.

The rescheduling of cannabis takes a pivotal turn as the DEA files final briefs before a key recommendation from an administrative judge.

The DEA grants federal registration to hundreds of medical cannabis dispensaries across multiple states, marking a significant policy shift.

Federal scrutiny evolves as 900+ medical cannabis dispensaries secure official registrations, paving the way for a new era in cannabis regulation.

The DEA grants federal registrations to state-legal operators six months after AG Todd Blanche initiated Schedule III rescheduling.

Sen. Cory Booker challenges DEA policy that penalizes marijuana businesses with employees holding prior nonviolent convictions, spotlighting implications for cannabis delivery and dispensaries.

A former adversary of the DEA and HHS now shapes federal drug reform as Deputy General Counsel, steering executive orders and clinical access.

Federal cannabis rescheduling is expected to pull producers under the same GMP standards that govern other consumed products, with new equipment rules likely to follow.

Treasury and the IRS say tax guidance tied to cannabis rescheduling is a top priority for 2026–2027, with big implications for Section 280E and mixed medical/adult-use operators.

A DEA administrative law judge halted the federal rescheduling proceeding to weigh a new GAO report on agency procedures—delaying a final ruling and keeping the status quo in place for now.

A DEA administrative law judge issued a stay on the wider adult-use rescheduling review, weighing a GAO report’s admission and extra briefing. The pause does not alter April’s medical marijuana move to Schedule III, per mg Magazine.

A DEA administrative judge granted opponents’ request to pause the federal marijuana rescheduling hearing so a GAO report on scheduling “gaps” can be entered. Here’s what that means in practice for DC, Maryland and Virginia.

A DEA administrative judge paused the cannabis rescheduling hearing to consider a GAO watchdog report on process gaps. A DEA response is due by October 13, adding delay and uncertainty.

As federal agents inspect medical dispensaries registering for Schedule III protections, new DEA inquiries reveal critical compliance guidelines.

NCIA's 14th Lobbying Days arrived on the heels of the DOJ's April order moving state-regulated medical cannabis to Schedule III. Here's what Congress heard—and what DMV-area consumers and delivery operators should watch.

DEA released thousands of pages from an 11-day July hearing on cannabis rescheduling. Here’s what was published, what’s still unknown, and how DMV readers should track it.

The DEA released the corrected 2,533-page marijuana rescheduling hearing transcript on Aug 25-26, 2026 — with 294 corrections including several that change the factual record. Here is what witnesses said under oath and what it means for DC, MD, and VA cannabis consumers. This article was researched and written with AI assistance by the Bud Lords AI Newsroom.

Toad Venom, pheno hunting, and drama weed are dominating cannabis culture in 2026. Learn what makes a strain go viral, how to separate hype from quality, and find premium flower in the DMV. This article was researched and written with AI assistance by the Bud Lords AI Newsroom.

Daily cannabis use now surpasses daily drinking in the US. Your 2026 THC beverage guide covers top launches like Verano Easy Landings and Wade x Cann, dosing tips, DMV legality, and where to shop. This article was researched and written with AI assistance by the Bud Lords AI Newsroom.

Virginia hemp retailers are shutting down as the CCA enforces $10,000/day penalties under the Aug 15 2mg THC cap. Store closures, enforcement details, and what is still legal for consumers in the DMV. This article was researched and written with AI assistance by the Bud Lords AI Newsroom.